Uniquecynax Healthcare Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 7.02 Cr
as on 23-10-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.68 Cr
as on 23-10-2024
- Revenue 314.12%
(FY 2023)
- Profit -19.06%
(FY 2023)
- Ebitda 195.83%
(FY 2023)
- Net Worth 527.82%
(FY 2023)
- Total Assets 4.41%
(FY 2023)
About Uniquecynax Healthcare
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.02 Cr.
The company currently has active open charges totaling ₹6.68 Cr.
Souvick Chatterjee and Abhijit Bhattacharya serve as directors at the Company.
- CIN/LLPIN
U85100WB2018PTC225254
- Company No.
225254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Uniquecynax Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Souvick Chatterjee  | Director | 17-Jan-2024 | Current |
| Abhijit Bhattacharya | Director | 25-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Uniquecynax Healthcare.
Uniquecynax Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 314.12% increase. The company also saw a substantial fall in profitability, with a 19.06% decrease in profit. The company's net worth Soared by an impressive increase of 527.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniquecynax Healthcare?
In 2023, Uniquecynax Healthcare had a promoter holding of 67.55% and a public holding of 32.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
24Online Info Technologies Private LimitedActive 6 years 8 monthsSouvick Chatterjee is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 10 Jan 2024 | ₹1.00 Cr | Open |
Indian Bank Creation Date: 28 Sep 2021 | ₹4.75 Cr | Open |
Others Creation Date: 20 Mar 2021 | ₹9.30 M | Open |
How Many Employees Work at Uniquecynax Healthcare?
Uniquecynax Healthcare has a workforce of 42 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniquecynax Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniquecynax Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
